Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-trace').style.display = (document.getElementById('cakeErr67f2de7a406e8-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2de7a406e8-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-code').style.display = (document.getElementById('cakeErr67f2de7a406e8-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-context').style.display = (document.getElementById('cakeErr67f2de7a406e8-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2de7a406e8-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2de7a406e8-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26684,
		&#039;title&#039; =&gt; &#039;All new medicines to come under price control -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;all-new-medicines-to-come-under-price-control-sushmi-dey-4674722&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674722,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26684,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26684,
	&#039;title&#039; =&gt; &#039;All new medicines to come under price control -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;all-new-medicines-to-come-under-price-control-sushmi-dey-4674722&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674722,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26684
$metaTitle = &#039;LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey&#039;
$metaKeywords = &#039;Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>All new medicines to come under price control -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.</p><p align="justify">The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.</p><p align="justify">Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.</p><p align="justify">In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.</p><p align="justify">While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.</p><p align="justify">&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. </p><p align="justify">The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.</p><p align="justify">The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-trace').style.display = (document.getElementById('cakeErr67f2de7a406e8-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2de7a406e8-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-code').style.display = (document.getElementById('cakeErr67f2de7a406e8-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-context').style.display = (document.getElementById('cakeErr67f2de7a406e8-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2de7a406e8-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2de7a406e8-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26684,
		&#039;title&#039; =&gt; &#039;All new medicines to come under price control -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;all-new-medicines-to-come-under-price-control-sushmi-dey-4674722&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674722,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26684,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26684,
	&#039;title&#039; =&gt; &#039;All new medicines to come under price control -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;all-new-medicines-to-come-under-price-control-sushmi-dey-4674722&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674722,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26684
$metaTitle = &#039;LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey&#039;
$metaKeywords = &#039;Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>All new medicines to come under price control -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.</p><p align="justify">The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.</p><p align="justify">Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.</p><p align="justify">In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.</p><p align="justify">While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.</p><p align="justify">&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. </p><p align="justify">The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.</p><p align="justify">The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-trace').style.display = (document.getElementById('cakeErr67f2de7a406e8-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2de7a406e8-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-code').style.display = (document.getElementById('cakeErr67f2de7a406e8-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2de7a406e8-context').style.display = (document.getElementById('cakeErr67f2de7a406e8-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2de7a406e8-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2de7a406e8-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26684,
		&#039;title&#039; =&gt; &#039;All new medicines to come under price control -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;all-new-medicines-to-come-under-price-control-sushmi-dey-4674722&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674722,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26684,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26684,
	&#039;title&#039; =&gt; &#039;All new medicines to come under price control -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;all-new-medicines-to-come-under-price-control-sushmi-dey-4674722&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674722,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26684
$metaTitle = &#039;LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey&#039;
$metaKeywords = &#039;Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare&#039;
$metaDesc = &#039;
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as &#039;new medicines&#039;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;Market launch and/or sale of a &#039;new drug&#039;, as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&amp;quot; NPPA said in a recent notice. &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/all-new-medicines-to-come-under-price-control-sushmi-dey-4674722.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>All new medicines to come under price control -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.</p><p align="justify">The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.</p><p align="justify">Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.</p><p align="justify">In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.</p><p align="justify">While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.</p><p align="justify">&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. </p><p align="justify">The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.</p><p align="justify">The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26684,
		'title' => 'All new medicines to come under price control -Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.
</p>
<p align="justify">
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
</p>
<p align="justify">
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
</p>
<p align="justify">
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
</p>
<p align="justify">
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
</p>
<p align="justify">
&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. 
</p>
<p align="justify">
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
</p>
<p align="justify">
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
</p>',
		'credit_writer' => 'The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'all-new-medicines-to-come-under-price-control-sushmi-dey-4674722',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674722,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26684,
	'metaTitle' => 'LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey',
	'metaKeywords' => 'Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare',
	'metaDesc' => '
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.</p><p align="justify">The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.</p><p align="justify">Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.</p><p align="justify">In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.</p><p align="justify">While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.</p><p align="justify">&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. </p><p align="justify">The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.</p><p align="justify">The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26684,
	'title' => 'All new medicines to come under price control -Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
<em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.
</p>
<p align="justify">
The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.
</p>
<p align="justify">
Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.
</p>
<p align="justify">
In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.
</p>
<p align="justify">
While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.
</p>
<p align="justify">
&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. 
</p>
<p align="justify">
The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.
</p>
<p align="justify">
The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold
</p>',
	'credit_writer' => 'The Times of India, 4 December, 2014, http://timesofindia.indiatimes.com/india/All-new-medicines-to-come-under-price-control/articleshow/45367402.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'all-new-medicines-to-come-under-price-control-sushmi-dey-4674722',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674722,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26684
$metaTitle = 'LATEST NEWS UPDATES | All new medicines to come under price control -Sushmi Dey'
$metaKeywords = 'Access to Healthcare,Access to Medicines,medicine,medicines,Health,healthcare'
$metaDesc = '
-The Times of India


NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA)...'
$disp = '<div align="justify">-The Times of India</div><p align="justify"><em>NEW DELHI: </em>The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'.</p><p align="justify">The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI.</p><p align="justify">Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore.</p><p align="justify">In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling.</p><p align="justify">While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually.</p><p align="justify">&quot;Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955,&quot; NPPA said in a recent notice. </p><p align="justify">The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products.</p><p align="justify">The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

All new medicines to come under price control -Sushmi Dey

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the price regulation of essential medicines, while also keeping a check on innovative branding and marketing strategies of pharmaceutical companies to circumvent price control, an official, in the know of developments, told TOI. Currently, prices of 374 medicines are directly capped by the government at the average price of those being sold with at least 1 per cent market share. This roughly accounts for 10-13% of the total domestic pharmaceutical market pegged at around Rs 79,000 crore. In order to escape price regulation, companies often launch newer combinations by making minor changes to existing price-controlled medicines. Sometimes, firms also tweak the strengths and dosages to bypass the price ceiling. While such products are launched as newer brands, companies benefit from such strategies because under the existing law, firms are free to fix the launch price of all medicines, other than the 374 that are directly under government control. Even for such medicines, companies are free to raise prices by up to 10% annually. "Market launch and/or sale of a 'new drug', as defined under paragraph 2 (u) of the DPCO (Drugs Price Control Order) 2013 without prior approval of retail price by the NPPA or where such approval stands withdrawn shall not only attract recovery of overcharged amount along with interest and penalty but also prosecution under Section 7 of the Essential Commodities Act, 1955," NPPA said in a recent notice. The regulator has also asked companies to submit a compliance certificate from Drug Controller General of India (DCGI), which monitors quality of medicines and gives approval to new products. The move is the latest among various stringent measures adopted by the government and the regulator in recent past to keep prices of medicines under check. The regulator has already proposed to revise the list of essential medicines to include medicine formulations that are commonly sold